Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
7.98
+0.22 (2.84%)
At close: Feb 12, 2026, 4:00 PM EST
7.94
-0.04 (-0.45%)
After-hours: Feb 12, 2026, 7:32 PM EST
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $658.93 million as of February 12, 2026. Its market cap has decreased by -39.14% in one year.
Market Cap
658.93M
Enterprise Value
466.14M
1-Year Change
-39.14%
Ranking
Category
Stock Price
$7.98
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $658.93M, an increase of 40.94%. That is a compound annual growth rate of 4.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 658.93M | -13.58% |
| Dec 31, 2025 | 762.47M | -18.18% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 716.44M |
| Gyre Therapeutics | 710.76M |
| Kura Oncology | 697.88M |
| Upstream Bio | 691.69M |
| Cullinan Therapeutics | 690.60M |
| YD Bio | 689.84M |
| Jade Biosciences | 681.32M |
| enGene Holdings | 665.83M |